A novel peptide specifically binding to nasopharyngeal carcinoma for targeted drug delivery.
about
Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potentialA liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or densityGeneration and Characterization of Monoclonal Antibodies against Dengue Virus Type 1 for Epitope Mapping and Serological Detection by Epitope-Based Peptide AntigensA novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancerTargeted drug delivery systems mediated by a novel Peptide in breast cancer therapy and imagingPeptide-mediated liposomal Doxorubicin enhances drug delivery efficiency and therapeutic efficacy in animal modelsPhage protein-targeted cancer nanomedicines.Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular ImagingData for peptide-binding assay with oriented immobilization of GRP78 in Biacore.Combinatorial peptide libraries: mining for cell-binding peptides.Selection of pancreatic cancer cell-binding landscape phages and their use in development of anticancer nanomedicines.Liposomes targeted by fusion phage proteinsAntiangiogenic targeting liposomes increase therapeutic efficacy for solid tumorsPeptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.Peptide-mediated liposomal drug delivery system targeting tumor blood vessels in anticancer therapy.Identification of peptide sequences that target to the brain using in vivo phage display.Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus.Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes.In vivo phage display screen for peptide sequences that cross the blood-cerebrospinal-fluid barrier.α-Enolase-binding peptide enhances drug delivery efficiency and therapeutic efficacy against colorectal cancer.Advancement and applications of peptide phage display technology in biomedical scienceTargeted delivery of paclitaxel to EphA2-expressing cancer cellsEpidermal growth factor receptor-targeted peptide conjugated phospholipid micelles for doxorubicin delivery.Hepatocellular carcinoma-targeted nanoparticles for cancer therapy.In vitro evaluation of the L-peptide modified magnetic lipid nanoparticles as targeted magnetic resonance imaging contrast agent for the nasopharyngeal cancer.A set of cancer stem cell homing peptides associating with the glycan moieties of glycosphingolipids.Application of Light Scattering Techniques to Nanoparticle Characterization and Development.Identification of oligopeptide binding to colon cancer cells separated from patients using laser capture microdissectionl-Peptide functionalized dual-responsive nanoparticles for controlled paclitaxel release and enhanced apoptosis in breast cancer cells
P2860
Q24657256-AC615A63-3BC1-4BC8-A23D-6C292A65D022Q27308658-25DB7604-2C65-4F7E-9D6F-D8991C2A1C1DQ27478354-E745DC0A-4FE6-466E-9B76-50111CA177A2Q28474508-277727A8-F43F-4504-BA0E-A7E45CF9C612Q28533782-E7839734-9195-4502-86FA-0EE7CCB6A801Q28538039-425AE935-8245-4272-B5B1-C8B3BC8478EAQ30403553-FAB40F6B-F273-403D-9CCD-D9AAC76EE881Q30851553-34082E3C-887D-40E4-A0FB-5064747910A3Q31137914-6F64AAED-82FC-46EA-AE15-9D641D797881Q31144876-E70BA30A-E22C-4F4C-84A6-19D4CEECB383Q31163147-D73F9B56-11C6-4307-B920-1DB4890F25BBQ33374206-88FC5D8C-1970-4A0B-B4CD-120F29049DB8Q33416674-08209C1B-3BC7-4E62-8BCC-E1D4C1B37C17Q33520512-DF202358-FFBE-409E-8582-4C337167A927Q33829569-92DAC9F3-7799-46B6-B665-4AFD09DBF7CAQ33972613-3486F944-B466-444A-B392-E49D1A37086FQ34684816-A10C8499-0D14-47E9-B756-E6AC1AC3C950Q35024345-8C2FD9EB-6AF2-437D-B4DE-5FA04165B8E4Q35435425-ADD7377C-7BE4-4D77-BE18-BAC6B430786DQ35652276-5E36D35C-A280-420D-9F40-D76B77765C2DQ35898339-2C245030-6E1F-491B-B0FC-C40F16C1A4B7Q36511070-5843E682-CC31-4272-99F8-5FDDE7540B09Q38852900-98851EF0-FDE6-4796-A010-B8FCC8C8B114Q47097723-B8DA9C2C-62C0-4B68-9B5C-27412C6E3A5BQ50239173-CB260C6C-C7B5-4ABD-BC57-9E52C120A08CQ55399318-FB0F962E-57AD-44FC-81A2-508C3F62B98BQ55516366-C18BF549-6266-4FB6-9884-ABA338587DEDQ56893974-1D054B5B-5FF3-496E-8D1A-6E0C57C5F16DQ57369521-8AA9AE34-3DF9-4303-9B42-12FDE5E51590
P2860
A novel peptide specifically binding to nasopharyngeal carcinoma for targeted drug delivery.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
A novel peptide specifically b ...... ma for targeted drug delivery.
@ast
A novel peptide specifically b ...... ma for targeted drug delivery.
@en
type
label
A novel peptide specifically b ...... ma for targeted drug delivery.
@ast
A novel peptide specifically b ...... ma for targeted drug delivery.
@en
prefLabel
A novel peptide specifically b ...... ma for targeted drug delivery.
@ast
A novel peptide specifically b ...... ma for targeted drug delivery.
@en
P2093
P1433
P1476
A novel peptide specifically b ...... ma for targeted drug delivery.
@en
P2093
Chin-Tarng Lin
Han-Chung Wu
Tong-Young Lee
Yun-Long Tseng
P304
P356
10.1158/0008-5472.CAN-04-1948
P407
P577
2004-11-01T00:00:00Z